Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that intermediate filaments and matrix proteins in presumptive hair shaft cells are synthesized sequentially, identifying a new polypeptide component that changes during hair cell differentiation.

This study demonstrated that biochemical analysis of proteins from fetal skin biopsies is feasible, potentially enhancing prenatal diagnostic capabilities for protein-related disorders.

This paper reviews the historical use and contemporary relevance of plant-derived cosmetics, focusing on Suriname's herbal cosmetics industry and the potential to establish a beauty products industry there, without presenting new findings.

This study quantified hair shedding in women without female pattern hair loss and found that about 40% experienced excessive shedding during hair washing, emphasizing the need for further research into this common concern.

This study found that MEGA PROTAC improved the prediction of ternary structures with higher maximum DockQ scores compared to the BOTCP method in 16 out of 22 test cases.

In this ongoing phase 3 study, ritlecitinib demonstrated sustained efficacy up to 24 months in patients aged 12 or older with alopecia areata, showing increased response rates with or without an initial loading dose and supporting its long-term use.

This article reviews the classification history of androgenic alopecia and highlights the need for further research to find effective hair growth medications.

This study found that repeated treatments with the long-pulsed ruby laser result in a small but statistically significant reduction in unwanted hair, with high patient satisfaction despite modest efficacy.

This study found that polymorphous light eruption (PLE) may include a wide range of conditions, requiring careful differentiation from similar skin disorders such as benign summer light eruption.

This study outlines a method for isolating dermal papilla cells from human hair follicles, which may help overcome challenges in studying their role in hair growth.

This study found increasing public interest in hair loss treatments on YouTube, but reported that videos with high viewer engagement are often biased towards promoting dermatology and hair restoration clinics.

This study determined the broad class and molecular species of glycerophospholipids in Eastern red bat sebum, highlighting differences from previous bat lung surfactant studies.

In this study, infectious skin conditions were observed more frequently in community settings than in a tertiary center, highlighting the need for improved dermatology services at the primary healthcare level.

This study found that patients over 45, those with obesity, and those experiencing 15 or more COVID-19 symptoms had a higher likelihood of developing severe long COVID-19.

This study found that minoxidil forms a reservoir in the skin, allowing sustained drug delivery even after cleansing, while propylene glycol does not.

This study examined phase 3 clinical trial data and found that baricitinib improves hair regrowth in adults with alopecia areata and significant scalp hair loss, with the response varying based on the severity of hair loss at the start of treatment.

This study found that 66.3% of primary healthcare center attendees in the Jazan region reported experiencing hair loss, with the majority being female and most commonly identifying telogen effluvium.

This study found that among alopecia patients, 64.5% had androgenetic alopecia, with a significant prevalence in individuals under age 30 and links to family history and androgen-associated conditions.

The document suggests fixing common hair transplant issues by combining artistic principles with plug reduction, recycling, and additional micrograft transplantation, while also potentially using arnica to help with post-operative swelling.

This study found that dermatologic adverse events are common in children taking MEK inhibitors, with selumetinib patients experiencing less severe reactions and a lower risk of dosage adjustments. Age was noted as a factor in the likelihood of specific skin reactions.

This article reviews the potential of bionanomaterials, derived from natural biomolecules, for wound healing and reports no new clinical results; it emphasizes the need for further research in this area.

This study reports that COVID-19 significantly decreased skin cancer diagnoses and referrals, with reductions of up to 60% observed in the Netherlands and similar trends in the UK and Australia.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

The researchers concluded that after the 2013 EMA recommendation, there was an overall reduction in CPA/EE prescriptions, but no substantial change in patient diagnoses or potential concurrent hormonal contraceptive use.

This study found that five 0.1 mg dutasteride capsules are bioequivalent to one 0.5 mg dutasteride capsule in healthy adult males under fasting conditions, and both were well tolerated.

This study found that full-thickness eyelid excision typically does not affect the number of eyelashes postoperatively, suggesting an increase in the growth phase of remaining follicles.

In this randomized study, BAY 1158061, a prolactin receptor antibody, was found to be safe, well-tolerated, and exhibited low immunogenicity in healthy postmenopausal women, but had no effect on serum prolactin levels compared to placebo.

In a post-hoc analysis of six trials, this study observed that both adult and pediatric patients with moderate-to-severe palmoplantar psoriasis treated with ixekizumab experienced rapid and complete clearance of lesions, sustained for up to 5 years in adults and 2 years in children.

This article confirms a significant rise in hair and scalp-related disorders at tertiary outpatient dermatology centers, particularly in cases of androgenetic alopecia and frontal fibrosing alopecia.

This study found that 5-α reductase inhibitors and neuropsychiatric medications were most frequently reported for erectile dysfunction in a national pharmacovigilance database from 2010 to 2020.